Thermo Fisher Scientific Inc.
Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%
Thermo Fisher Scientific Clinical Diagnostics by Quarter
Clinical Diagnostics (Clinical Diagnostics & Specialty Testing) ($M)
Thermo Fisher Scientific Clinical Diagnostics: $290M in Q2 2026, up 5.1% from a year earlier.
Where the Q2 2026 figure comes from
“|| Clinical diagnostics | 290 | 276 | 561 | 539”
Source: SEC Form 10-Q (10q_2026Q2, filed 2026-07-31) ↗
Reported in SEC 10-K / 10-Q Note 6 (Revenue by Business).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Clinical Diagnostics (Clinical Diagnostics & Specialty Testing) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 290 | +5.1% | SEC Form 10-Q (10q_2026Q2, filed 2026-07-31) ↗ |
| Q1 2026 | Mar 31, 2026 | 271 | +3.0% | SEC Form 10-Q (10q_2026Q1, filed 2026-05-01) ↗ |
| Q4 2025 | Dec 31, 2025 | 293 | +12.3% | SEC Form 10-K (10k_2025, filed 2026-02-26) ↗ |
| Q3 2025 | Sep 30, 2025 | 283 | +6.4% | SEC Form 10-Q (10q_2025Q3, filed 2025-10-31) ↗ |
| Q2 2025 | Jun 30, 2025 | 276 | +1.1% | SEC Form 10-Q (10q_2026Q2, filed 2026-07-31) ↗ |
| Q1 2025 | Mar 31, 2025 | 263 | 0.0% | SEC Form 10-Q (10q_2026Q1, filed 2026-05-01) ↗ |
| Q4 2024 | Dec 31, 2024 | 261 | – | SEC Form 10-K (10k_2025, filed 2026-02-26) ↗ |
| Q3 2024 | Sep 30, 2024 | 266 | – | SEC Form 10-Q (10q_2025Q3, filed 2025-10-31) ↗ |
| Q2 2024 | Jun 30, 2024 | 273 | – | SEC Form 10-Q (10q_2025Q2, filed 2025-08-01) ↗ |
| Q1 2024 | Mar 31, 2024 | 263 | – | SEC Form 10-Q (10q_2025Q1, filed 2025-05-02) ↗ |
Cite this data
StockData. (2026). Thermo Fisher Scientific Clinical Diagnostics ($M), quarterly Q1 2024–Q2 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/rev-biz-clinical-diagnostics
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.